Healthcare -
Biotechnology - NASDAQ - US
$ 9.08
4.73 %
$ 531 M
Market Cap
-3.27
P/E
CGEM - CAPITAL EXPENDITURES
Capital Expenditures CGEM - Cullinan Oncology, Inc.
-208 K
LAST VALUE
40.59%
2 YEAR CAGR
4.44%
5 YEAR CAGR
0.00%
10 YEAR CAGR